Tirzepatide Peptide (GIP/GLP-1 Dual Agonist) – High Purity ≥99% | cGMP Grade for Metabolic Research _ Premium Tirzepatide for Sale.

Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual agonist for the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It represents a significant advancement in metabolic research, combining the complementary actions of both incretin pathways.

As a unimolecular dual agonist, Tirzepatide activates GIP and GLP-1 receptors with high affinity. GIP receptor activation complements GLP-1 by enhancing insulin secretion, improving lipid metabolism, and potentially reducing nausea commonly associated with GLP-1 monotherapy. This dual mechanism provides distinct research advantages over single-agonist peptides.

Looking for Tirzepatide for sale from a trusted supplier? Shanghai AmbioPharm, Inc. offers high purity Tirzepatide peptide manufactured under advanced, quality-controlled environments to support cutting-edge research applications. Tirzepatide is widely studied in metabolic and peptide research due to its dual-action mechanism, making it a highly sought-after compound in scientific and biotech laboratories.

Our Tirzepatide peptide is synthesized using pharmaceutical-grade processes to ensure ≥99% purity, excellent stability, and consistent batch performance. Each order includes a Certificate of Analysis (COA), providing full transparency and verification of product quality. With our manufacturing facility in Shanghai and USA-based distribution support, we ensure fast, secure shipping and dependable supply for both small-scale and bulk orders.

Tirzepatide incorporates a C20 fatty diacid moiety that enables albumin binding, extending its research half-life to approximately 5 days, making it suitable for once-weekly dosing models.

At Shanghai AmbioPharm, Inc., we supply high-purity Tirzepatide (≥99% by HPLC) for advanced metabolic research. Our cGMP-grade material is synthesized in our FDA-inspected Shanghai facility and available for fast U.S. delivery from our Clearwater, South Carolina warehouse.

Key Product Details:

• Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(N-ε-(20-(2,5-dioxopyrrolidin-1-yl)oxy-20-oxoicosanoyl))-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂

• CAS Number: 2023788-19-2

• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈

• Molecular Weight: 4,813.3 g/mol

• Purity: ≥99% (HPLC)

• Form: Lyophilized white powder

• Storage: -20°C, protected from light, desiccated

• Grade Available: Non-GMP (R&D) and cGMP (clinical preparatory)

• Research Half-Life: Approximately 5 days (albumin-bound)

• Amino Acids: 39-mer

• Key Modifications: Aib substitutions (DPP-IV resistance), C20 fatty diacid (albumin binding), C-terminal amidation

Why Choose AmbioPharm for Tirzepatide?

As a global peptide CDMO, AmbioPharm combines scientific expertise with large-scale manufacturing capabilities. Choosing our Tirzepatide for sale ensures premium quality, trusted sourcing, and reliable delivery tailored to your research needs.

• ✅ FDA-inspected cGMP manufacturing

• ✅ Full Certificate of Analysis (COA) with each batch

• ✅ HPLC chromatogram and mass spec data included

• ✅ Verified fatty acid conjugation confirmation

• ✅ Low endotoxin levels (<1 EU/mg)

• ✅ U.S. warehousing – fast domestic shipping from South Carolina

• ✅ Batch-to-batch consistency for longitudinal metabolic studies

Research Applications:

• Dual incretin receptor pharmacology (GIP + GLP-1)

• Insulin secretion and glucose homeostasis studies

• Appetite regulation and food intake research

• Lipid metabolism and body composition models

• Beta-cell preservation and function research

• Metabolic syndrome and obesity research models

• Cardiovascular and hepatic steatosis studies

• Comparative efficacy vs. single-agonist peptides

Mechanism of Action:
Tirzepatide activates both GIP and GLP-1 receptors on pancreatic beta cells, enhancing glucose-dependent insulin secretion. GIP activation also promotes lipid storage in adipose tissue and reduces food intake via CNS pathways. The C20 fatty diacid enables reversible albumin binding, extending half-life while maintaining target engagement.

 Intended Use: For laboratory research purposes only. Not for human consumption or clinical use without regulatory approval.

Ordering Information:

• Minimum Order Quantity (MOQ): 10mg (R&D), 10g+ (cGMP bulk)

• Lead Time: 2-3 weeks (non-GMP), 6-8 weeks (cGMP)

• Shipping: From Clearwater, SC, USA (2-5 days domestic)